Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 17,350
+138 (0.80%)
At close: Jun 19, 2026
Neuland Laboratories Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Neuland Laboratories stock has a consensus rating of "Strong Buy" and an average price target of ₹20,972. The average 1-year stock price forecast is 20.88% higher than the current stock price, while the lowest is ₹19,550 (+12.68%) and the highest is ₹22,913 (+32.07%).
Price Target: ₹20,972 (+20.88%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neuland Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
23.33B
from 20.23B
Increased by 15.32%
Revenue Next Year
28.04B
from 23.33B
Increased by 20.20%
EPS This Year
333.80
from 283.71
Increased by 17.66%
EPS Next Year
457.80
from 333.80
Increased by 37.15%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 24.6B | ||
| Avg | 23.3B | ||
| Low | 22.3B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 21.4% | ||
| Avg | 15.3% | ||
| Low | 10.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 333.80 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 17.7% | ||
| Low | - |